These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 18558445)

  • 1. Microtiter plate bioassay to monitor the interference of antibiotics with the lipid II cycle essential for peptidoglycan biosynthesis.
    Burkard M; Stein T
    J Microbiol Methods; 2008 Sep; 75(1):70-4. PubMed ID: 18558445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoregulation of subtilin biosynthesis in Bacillus subtilis: the role of the spa-box in subtilin-responsive promoters.
    Kleerebezem M; Bongers R; Rutten G; de Vos WM; Kuipers OP
    Peptides; 2004 Sep; 25(9):1415-24. PubMed ID: 15374645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A lesson in efficient killing from two-component lantibiotics.
    Breukink E
    Mol Microbiol; 2006 Jul; 61(2):271-3. PubMed ID: 16771845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mode of action of the lantibiotic lacticin 3147--a complex mechanism involving specific interaction of two peptides and the cell wall precursor lipid II.
    Wiedemann I; Böttiger T; Bonelli RR; Wiese A; Hagge SO; Gutsmann T; Seydel U; Deegan L; Hill C; Ross P; Sahl HG
    Mol Microbiol; 2006 Jul; 61(2):285-96. PubMed ID: 16771847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial mechanism of lantibiotics.
    Islam MR; Nagao J; Zendo T; Sonomoto K
    Biochem Soc Trans; 2012 Dec; 40(6):1528-33. PubMed ID: 23176511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An alternative bactericidal mechanism of action for lantibiotic peptides that target lipid II.
    Hasper HE; Kramer NE; Smith JL; Hillman JD; Zachariah C; Kuipers OP; de Kruijff B; Breukink E
    Science; 2006 Sep; 313(5793):1636-7. PubMed ID: 16973881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid II: a central component in bacterial cell wall synthesis and a target for antibiotics.
    de Kruijff B; van Dam V; Breukink E
    Prostaglandins Leukot Essent Fatty Acids; 2008; 79(3-5):117-21. PubMed ID: 19008088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ring A of nukacin ISK-1: a lipid II-binding motif for type-A(II) lantibiotic.
    Islam MR; Nishie M; Nagao J; Zendo T; Keller S; Nakayama J; Kohda D; Sahl HG; Sonomoto K
    J Am Chem Soc; 2012 Feb; 134(8):3687-90. PubMed ID: 22329487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights into in vivo activities of lantibiotics from gallidermin and epidermin mode-of-action studies.
    Bonelli RR; Schneider T; Sahl HG; Wiedemann I
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1449-57. PubMed ID: 16569864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic response of Bacillus subtilis to lantibiotics reflects differences in interaction with the cytoplasmic membrane.
    Wenzel M; Kohl B; Münch D; Raatschen N; Albada HB; Hamoen L; Metzler-Nolte N; Sahl HG; Bandow JE
    Antimicrob Agents Chemother; 2012 Nov; 56(11):5749-57. PubMed ID: 22926563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plectasin, a fungal defensin, targets the bacterial cell wall precursor Lipid II.
    Schneider T; Kruse T; Wimmer R; Wiedemann I; Sass V; Pag U; Jansen A; Nielsen AK; Mygind PH; Raventós DS; Neve S; Ravn B; Bonvin AM; De Maria L; Andersen AS; Gammelgaard LK; Sahl HG; Kristensen HH
    Science; 2010 May; 328(5982):1168-72. PubMed ID: 20508130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and application of a microtiter plate-based autoinduction bioassay for detection of the lantibiotic subtilin.
    Burkard M; Entian KD; Stein T
    J Microbiol Methods; 2007 Jul; 70(1):179-85. PubMed ID: 17532072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hit 'em where it hurts: The growing and structurally diverse family of peptides that target lipid-II.
    Oppedijk SF; Martin NI; Breukink E
    Biochim Biophys Acta; 2016 May; 1858(5):947-57. PubMed ID: 26523408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LiaRS reporter assay: A simple tool to identify lipid II binding moieties in lantibiotic nukacin ISK-1.
    Elsayed KM; Islam MR; Abdullah-Al-Mahin ; Nagao JI; Zendo T; Sonomoto K
    J Biosci Bioeng; 2017 Mar; 123(3):398-401. PubMed ID: 27856233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mode of action of lipid II-targeting lantibiotics.
    Bauer R; Dicks LM
    Int J Food Microbiol; 2005 May; 101(2):201-16. PubMed ID: 15862882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of colicin M and its orthologs targeting bacterial cell wall peptidoglycan biosynthesis.
    Barreteau H; El Ghachi M; Barnéoud-Arnoulet A; Sacco E; Touzé T; Duché D; Gérard F; Brooks M; Patin D; Bouhss A; Blanot D; van Tilbeurgh H; Arthur M; Lloubès R; Mengin-Lecreulx D
    Microb Drug Resist; 2012 Jun; 18(3):222-9. PubMed ID: 22432709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid II and other bactoprenol-bound cell wall precursors as drug targets.
    Schneider T; Sahl HG
    Curr Opin Investig Drugs; 2010 Feb; 11(2):157-64. PubMed ID: 20112165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maturation and processing of SpaI, the lipoprotein involved in subtilin immunity in Bacillus subtilis ATCC 6633.
    Halami PM; Stein T; Chandrashekar A; Entian KD
    Microbiol Res; 2010 Mar; 165(3):183-9. PubMed ID: 19540743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The lantibiotic mersacidin inhibits peptidoglycan biosynthesis at the level of transglycosylation.
    Brötz H; Bierbaum G; Reynolds PE; Sahl HG
    Eur J Biochem; 1997 May; 246(1):193-9. PubMed ID: 9210483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An oldie but a goodie - cell wall biosynthesis as antibiotic target pathway.
    Schneider T; Sahl HG
    Int J Med Microbiol; 2010 Feb; 300(2-3):161-9. PubMed ID: 20005776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.